Chemical materials

Pelgifatamab (anti-PSMA)

Pelgifatamab (anti-PSMA)

AL-AB182972 / 10MG
CAS No.:2414550-93-7
Add to Inquiry
Pelgifatamab (anti-PSMA)

Pelgifatamab (anti-PSMA)

AL-AB182972 / 5MG
CAS No.:2414550-93-7
Add to Inquiry
Pelgifatamab (anti-PSMA)

Pelgifatamab (anti-PSMA)

AL-AB182972 / 1MG
CAS No.:2414550-93-7
Add to Inquiry
Pelgifatamab (anti-PSMA)

Pelgifatamab (anti-PSMA)

AL-AB182972 / 100ΜG
CAS No.:2414550-93-7
Add to Inquiry
Vobramitamab (anti-CD276)

Vobramitamab (anti-CD276)

AL-AB182976 / 1MG
CAS No.:2490556-50-6
Add to Inquiry
Vobramitamab (anti-CD276)

Vobramitamab (anti-CD276)

AL-AB182976 / 5MG
CAS No.:2490556-50-6
Add to Inquiry
Vobramitamab (anti-CD276)

Vobramitamab (anti-CD276)

AL-AB182976 / 10MG
CAS No.:2490556-50-6
Add to Inquiry
Vobramitamab (anti-CD276)

Vobramitamab (anti-CD276)

AL-AB182976 / 100ΜG
CAS No.:2490556-50-6
Add to Inquiry
Barzolvolimab (anti-c-Kit)

Barzolvolimab (anti-c-Kit)

AL-AB182977 / 100ΜG
CAS No.:2438203-51-9
Add to Inquiry
Barzolvolimab (anti-c-Kit)

Barzolvolimab (anti-c-Kit)

AL-AB182977 / 10MG
CAS No.:2438203-51-9
Add to Inquiry
Barzolvolimab (anti-c-Kit)

Barzolvolimab (anti-c-Kit)

AL-AB182977 / 1MG
CAS No.:2438203-51-9
Add to Inquiry
Barzolvolimab (anti-c-Kit)

Barzolvolimab (anti-c-Kit)

AL-AB182977 / 5MG
CAS No.:2438203-51-9
Add to Inquiry
Rosnilimab (anti-PD-1)

Rosnilimab (anti-PD-1)

AL-AB182979 / 1MG
CAS No.:2412764-40-8
Add to Inquiry
Rosnilimab (anti-PD-1)

Rosnilimab (anti-PD-1)

AL-AB182979 / 5MG
CAS No.:2412764-40-8
Add to Inquiry
Rosnilimab (anti-PD-1)

Rosnilimab (anti-PD-1)

AL-AB182979 / 10MG
CAS No.:2412764-40-8
Add to Inquiry
Rosnilimab (anti-PD-1)

Rosnilimab (anti-PD-1)

AL-AB182979 / 100ΜG
CAS No.:2412764-40-8
Add to Inquiry
Visugromab (anti-GDF15)

Visugromab (anti-GDF15)

AL-AB182987 / 1MG
CAS No.:2556646-63-8
Add to Inquiry
Visugromab (anti-GDF15)

Visugromab (anti-GDF15)

AL-AB182987 / 100ΜG
CAS No.:2556646-63-8
Add to Inquiry
Visugromab (anti-GDF15)

Visugromab (anti-GDF15)

AL-AB182987 / 10MG
CAS No.:2556646-63-8
Add to Inquiry
Visugromab (anti-GDF15)

Visugromab (anti-GDF15)

AL-AB182987 / 5MG
CAS No.:2556646-63-8
Add to Inquiry
Tifcemalimab (anti-BTLA)

Tifcemalimab (anti-BTLA)

AL-AB182990 / 5MG
Add to Inquiry
Tifcemalimab (anti-BTLA)

Tifcemalimab (anti-BTLA)

AL-AB182990 / 100ΜG
Add to Inquiry
Tifcemalimab (anti-BTLA)

Tifcemalimab (anti-BTLA)

AL-AB182990 / 10MG
Add to Inquiry
Tifcemalimab (anti-BTLA)

Tifcemalimab (anti-BTLA)

AL-AB182990 / 1MG
Add to Inquiry
Peresolimab (anti-PD-1)

Peresolimab (anti-PD-1)

AL-AB182993 / 1MG
CAS No.:2411580-63-5
Add to Inquiry
Peresolimab (anti-PD-1)

Peresolimab (anti-PD-1)

AL-AB182993 / 100ΜG
CAS No.:2411580-63-5
Add to Inquiry
Peresolimab (anti-PD-1)

Peresolimab (anti-PD-1)

AL-AB182993 / 5MG
CAS No.:2411580-63-5
Add to Inquiry
Peresolimab (anti-PD-1)

Peresolimab (anti-PD-1)

AL-AB182993 / 10MG
CAS No.:2411580-63-5
Add to Inquiry
Linvoseltamab (anti-BCMA&CD3)

Linvoseltamab (anti-BCMA&CD3)

AL-AB182996 / 100ΜG
CAS No.:2408319-25-3
Add to Inquiry
Linvoseltamab (anti-BCMA&CD3)

Linvoseltamab (anti-BCMA&CD3)

AL-AB182996 / 10MG
CAS No.:2408319-25-3
Add to Inquiry
Linvoseltamab (anti-BCMA&CD3)

Linvoseltamab (anti-BCMA&CD3)

AL-AB182996 / 5MG
CAS No.:2408319-25-3
Add to Inquiry
Linvoseltamab (anti-BCMA&CD3)

Linvoseltamab (anti-BCMA&CD3)

AL-AB182996 / 1MG
CAS No.:2408319-25-3
Add to Inquiry
Osemitamab (anti-CLDN18.2)

Osemitamab (anti-CLDN18.2)

AL-AB183000 / 5MG
CAS No.:2460539-61-9
Add to Inquiry
Osemitamab (anti-CLDN18.2)

Osemitamab (anti-CLDN18.2)

AL-AB183000 / 100ΜG
CAS No.:2460539-61-9
Add to Inquiry
Osemitamab (anti-CLDN18.2)

Osemitamab (anti-CLDN18.2)

AL-AB183000 / 10MG
CAS No.:2460539-61-9
Add to Inquiry
Osemitamab (anti-CLDN18.2)

Osemitamab (anti-CLDN18.2)

AL-AB183000 / 1MG
CAS No.:2460539-61-9
Add to Inquiry
Mipasetamab (anti-AXL)

Mipasetamab (anti-AXL)

AL-AB183002 / 5MG
CAS No.:2361055-48-1
Add to Inquiry
Mipasetamab (anti-AXL)

Mipasetamab (anti-AXL)

AL-AB183002 / 100ΜG
CAS No.:2361055-48-1
Add to Inquiry
Mipasetamab (anti-AXL)

Mipasetamab (anti-AXL)

AL-AB183002 / 10MG
CAS No.:2361055-48-1
Add to Inquiry
Mipasetamab (anti-AXL)

Mipasetamab (anti-AXL)

AL-AB183002 / 1MG
CAS No.:2361055-48-1
Add to Inquiry
Pivekimab (anti-CD123)

Pivekimab (anti-CD123)

AL-AB183003 / 1MG
CAS No.:2234335-84-1
Add to Inquiry
Pivekimab (anti-CD123)

Pivekimab (anti-CD123)

AL-AB183003 / 100ΜG
CAS No.:2234335-84-1
Add to Inquiry
Pivekimab (anti-CD123)

Pivekimab (anti-CD123)

AL-AB183003 / 5MG
CAS No.:2234335-84-1
Add to Inquiry
Pivekimab (anti-CD123)

Pivekimab (anti-CD123)

AL-AB183003 / 10MG
CAS No.:2234335-84-1
Add to Inquiry
Abciximab (anti-Integrin αIIbβ3)

Abciximab (anti-Integrin αIIbβ3)

AL-AB183009 / 100ΜG
CAS No.:143653-53-6
Add to Inquiry
Abciximab (anti-Integrin αIIbβ3)

Abciximab (anti-Integrin αIIbβ3)

AL-AB183009 / 10MG
CAS No.:143653-53-6
Add to Inquiry
Abciximab (anti-Integrin αIIbβ3)

Abciximab (anti-Integrin αIIbβ3)

AL-AB183009 / 5MG
CAS No.:143653-53-6
Add to Inquiry
Abciximab (anti-Integrin αIIbβ3)

Abciximab (anti-Integrin αIIbβ3)

AL-AB183009 / 1MG
CAS No.:143653-53-6
Add to Inquiry
Reslizumab (anti-IL-5)

Reslizumab (anti-IL-5)

AL-AB183026 / 1MG
CAS No.:241473-69-8
Add to Inquiry
Reslizumab (anti-IL-5)

Reslizumab (anti-IL-5)

AL-AB183026 / 100ΜG
CAS No.:241473-69-8
Add to Inquiry
LOCATIONS

Service location

Taipei, New Taipei, Keelung / Yilan / Hualien
Inquiry Cart

Your inquiry Cart total 0 items

In accordance with the EU General Data Protection Regulation, we are committed to protecting your personal data and providing you with control over your personal data.
By clicking "Accept All," you allow us to place cookies to enhance your experience on this website, help us analyze website performance and usage, and enable us to deliver relevant marketing content. You can manage your cookie settings below. Clicking "Confirm" means you agree to the current settings.
Manage Cookies

Privacy Preference Center

In accordance with the EU General Data Protection Regulation, we are committed to protecting your personal data and providing you with control over your personal data.
By clicking "Accept All," you allow us to place cookies to enhance your experience on this website, help us analyze website performance and usage, and enable us to deliver relevant marketing content. You can manage your cookie settings below. Clicking "Confirm" means you agree to the current settings.
View Privacy Policy

Manage Consent Settings

Necessary Cookies

Enable all
The operation of the website relies on these cookies, and you cannot disable them in the system. These cookies are usually set based on the actions you take (i.e., service requests), such as setting privacy preferences, logging in, or filling out forms. You can set your browser to block or prompt you about these cookies, but this may cause some website functions to stop working.